Concepedia

Publication | Closed Access

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer

230

Citations

17

References

2018

Year

Abstract

CLDN18.2-specific CAR T cells could be a promising treatment strategy for gastric cancer and potentially other CLDN18.2-positive tumors.

References

YearCitations

Page 1